does umr cover glp-1 for weight loss Medication in 2025? Staff insurance rate increase overview

P., Thissen, J

GLP-1 use is rising (even in comp)

Analyst Emmanuel Papadakis said the key takeaway was that Novo is cautiously optimistic its cagrisema...

CSK&D is conducting an active class action investigation pertaining to oral tirzepatide drops sold by Willow Health.

WHO GLP-1 Treatments: The World Health Organization has issued new guidelines endorsing GLP-1 agonists as essential treatments for obesity, highlighting the urgent need for action against the rising global obesity epidemic affecting over one billion people and posing serious health risks.

According to allegations raised in an Ozempic lawsuit filed against Novo Nordisk, side effects of the diabetes drug caused the plaintiffs intestines to fail to contract, resulting in the need for hospitalization and permanent injuries.